COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

Introduction and objectives Vaccines against SARS-CoV-2 have been a major scientific and
medical achievement in the control of the COVID-19 pandemic. However, very infrequent …

Two messenger RNA (mRNA) vaccines of BNT162b2 and mRNA‐1273 were licensed. The
most common adverse event is regional pain at the injection site in 80%. As systemic …

Patients with a history of cardiovascular disease (CVD) who contract coronavirus disease
2019 (COVID-19) tend to have a worse prognosis and more severe cardiovascular side …

The launch of the COVID-19 vaccination program was the largest vaccination campaign in
US history, with an unprecedented demand for vaccine and new vaccination providers …

As a retired physician, I have been wrestling with longer-term cardiorespiratory
complications of COVID-19. 1 The central chest pain with neck radiation that I experienced …

Background Increasing evidence indicating that coronavirus disease 2019 (COVID-19)
increased the incidence and related risks of pericarditis and whether COVID-19 vaccine is …

As vaccination against COVID-19 became more widespread, side-effects that were not
initially detected during clinical trials became more prominent. The aim of this systematic …

Background Several reports of unheeded complications secondary to the current mass
international rollout of SARS-COV-2 vaccines, one of which is myocarditis occurring with the …

Highlights•Myocardial damage is a typical cardiac manifestation following SARS-CoV-2
infection.•Mechanisms include inflammation, oxidative stress, innate immune response …